PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
KEQU vs. FXAIX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between KEQU and FXAIX is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

KEQU vs. FXAIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kewaunee Scientific Corporation (KEQU) and Fidelity 500 Index Fund (FXAIX). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%AugustSeptemberOctoberNovemberDecember2025
7.58%
3.79%
KEQU
FXAIX

Key characteristics

Sharpe Ratio

KEQU:

1.53

FXAIX:

1.88

Sortino Ratio

KEQU:

2.41

FXAIX:

2.51

Omega Ratio

KEQU:

1.30

FXAIX:

1.35

Calmar Ratio

KEQU:

2.17

FXAIX:

2.83

Martin Ratio

KEQU:

5.12

FXAIX:

11.87

Ulcer Index

KEQU:

18.75%

FXAIX:

2.02%

Daily Std Dev

KEQU:

62.82%

FXAIX:

12.77%

Max Drawdown

KEQU:

-79.95%

FXAIX:

-33.79%

Current Drawdown

KEQU:

-14.76%

FXAIX:

-3.94%

Returns By Period

In the year-to-date period, KEQU achieves a -9.63% return, which is significantly lower than FXAIX's -0.62% return. Over the past 10 years, KEQU has outperformed FXAIX with an annualized return of 14.22%, while FXAIX has yielded a comparatively lower 13.08% annualized return.


KEQU

YTD

-9.63%

1M

4.72%

6M

7.58%

1Y

98.19%

5Y*

35.60%

10Y*

14.22%

FXAIX

YTD

-0.62%

1M

-3.35%

6M

3.79%

1Y

23.82%

5Y*

13.82%

10Y*

13.08%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

KEQU vs. FXAIX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KEQU
The Risk-Adjusted Performance Rank of KEQU is 8888
Overall Rank
The Sharpe Ratio Rank of KEQU is 8989
Sharpe Ratio Rank
The Sortino Ratio Rank of KEQU is 8888
Sortino Ratio Rank
The Omega Ratio Rank of KEQU is 8686
Omega Ratio Rank
The Calmar Ratio Rank of KEQU is 9292
Calmar Ratio Rank
The Martin Ratio Rank of KEQU is 8383
Martin Ratio Rank

FXAIX
The Risk-Adjusted Performance Rank of FXAIX is 9191
Overall Rank
The Sharpe Ratio Rank of FXAIX is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of FXAIX is 9090
Sortino Ratio Rank
The Omega Ratio Rank of FXAIX is 8989
Omega Ratio Rank
The Calmar Ratio Rank of FXAIX is 9292
Calmar Ratio Rank
The Martin Ratio Rank of FXAIX is 9292
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

KEQU vs. FXAIX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Kewaunee Scientific Corporation (KEQU) and Fidelity 500 Index Fund (FXAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for KEQU, currently valued at 1.53, compared to the broader market-2.000.002.001.531.88
The chart of Sortino ratio for KEQU, currently valued at 2.41, compared to the broader market-4.00-2.000.002.004.002.412.51
The chart of Omega ratio for KEQU, currently valued at 1.30, compared to the broader market0.501.001.502.001.301.35
The chart of Calmar ratio for KEQU, currently valued at 2.17, compared to the broader market0.002.004.006.002.172.83
The chart of Martin ratio for KEQU, currently valued at 5.12, compared to the broader market0.0010.0020.005.1211.87
KEQU
FXAIX

The current KEQU Sharpe Ratio is 1.53, which is comparable to the FXAIX Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of KEQU and FXAIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
1.53
1.88
KEQU
FXAIX

Dividends

KEQU vs. FXAIX - Dividend Comparison

KEQU has not paid dividends to shareholders, while FXAIX's dividend yield for the trailing twelve months is around 1.25%.


TTM20242023202220212020201920182017201620152014
KEQU
Kewaunee Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%4.24%2.17%2.21%2.29%2.81%2.58%
FXAIX
Fidelity 500 Index Fund
1.25%1.25%1.45%1.69%1.22%1.60%1.95%2.07%1.81%2.01%2.56%2.63%

Drawdowns

KEQU vs. FXAIX - Drawdown Comparison

The maximum KEQU drawdown since its inception was -79.95%, which is greater than FXAIX's maximum drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for KEQU and FXAIX. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-14.76%
-3.94%
KEQU
FXAIX

Volatility

KEQU vs. FXAIX - Volatility Comparison

Kewaunee Scientific Corporation (KEQU) has a higher volatility of 29.27% compared to Fidelity 500 Index Fund (FXAIX) at 4.57%. This indicates that KEQU's price experiences larger fluctuations and is considered to be riskier than FXAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
29.27%
4.57%
KEQU
FXAIX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab